Research from our laboratory, and others1,6, has shown that acetylation of MnSOD disrupts normal cellular and mitochondrial metabolism, leading to a tumor-permissive phenotype, suggesting that MnSOD is an adaptive enzyme responding to cellular oxidative stress7–9. Here, SOD2 is linked to neoplasm.